- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- January 2025
- 140 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- December 2024
- 144 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Clinical Trials
- November 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Clinical Trials
- March 2025
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Clinical Trials
- March 2025
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- December 2024
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Drug Pipelines
- November 2024
- 240 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Drug Pipelines
- November 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- July 2024
- 100 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Clinical Trials
- July 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 210 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1432EUR$1,500USD£1,199GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more